Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: Its association with tumor progression and proliferation

Akifumi Hayashi, Shinichi Aishima, Yoshihiro Miyasaka, Kohei Nakata, Katsuya Morimatsu, Yasunori Oda, Eishi Nagai, Yoshinao Oda, Masao Tanaka, Masazumi Tsuneyoshi

研究成果: Contribution to journalArticle査読

14 被引用数 (Scopus)

抄録

Intraductal papillary mucinous neoplasm is characterized by cystically dilated main and/or branch pancreatic duct with mucus. According to the degree of atypia, intraductal papillary mucinous neoplasm is classified into 3 groups: adenoma, borderline, and carcinoma. Furthermore, intraductal papillary mucinous neoplasm is considered to progress through an adenoma-carcinoma sequence like colorectal carcinoma. Programmed cell death 4 is a recently identified tumor suppressor that was found to inhibit translation. Programmed cell death 4 has been reported to inhibit tumorigenesis, tumor progression, proliferation, invasion, and metastasis in several human malignancies. We examined 108 cases of intraductal papillary mucinous neoplasm by immunohistochemistry and revealed that programmed cell death 4 expression was recognized in both the nucleus and cytoplasm in intraductal papillary mucinous neoplasm. The positive rate of programmed cell death 4 was 79%, 43%, and 10% in adenoma, borderline, and carcinoma, respectively. The positive rate of programmed cell death 4 decreased from adenoma to carcinoma (P < .0001, both adenoma versus borderline and borderline versus carcinoma), indicating that programmed cell death 4 might inhibit tumor progression in intraductal papillary mucinous neoplasm. Programmed cell death 4 expression had a strong relationship with p21 expression (P < .0001) and an inverse correlation with Ki-67 labeling index (r = -0.6255, P < .0001). Thus, programmed cell death 4 might inhibit the proliferation of intraductal papillary mucinous neoplasm; and its inhibition might partly result from cell cycle arrest caused by the up-regulation of p21. In conclusion, programmed cell death 4 may inhibit tumor progression in intraductal papillary mucinous neoplasm; and the loss of programmed cell death 4 expression is representative of the malignant potential of intraductal papillary mucinous neoplasm including the proliferative activity. Therefore, programmed cell death 4 can be an important biomarker for intraductal papillary mucinous neoplasm.

本文言語英語
ページ(範囲)1507-1515
ページ数9
ジャーナルHuman Pathology
41
11
DOI
出版ステータス出版済み - 11 2010

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

フィンガープリント 「Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: Its association with tumor progression and proliferation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル